Donald Trump's views on health care are murky, to say the least. While the billionaire businessman once voiced support for a single-payer system mirroring that of Canada, he doesn't say much these days about health care beyond promising to scrap PPACA and replace it with "something terrific."
In addition, he said that the controversial head of a drug company "looks like a spoiled brat."
The comment amounted to Trump's two cents on a recent controversy that erupted over Martin Shkreli, the 32-year-old founder and CEO of Turing Pharmaceutical, suddenly raising the price of a key medication from $13.50 per pill to $750 per pill. After widespread outrage, Shkreli quickly backpedaled, announcing Wednesday that he would lower the price, although he has not yet said by how much.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
